Skip to main content
. 2018 May;57(3):268–277. doi: 10.30802/AALAS-JAALAS-17-000131

Table 2.

Effects of urethane–xylazine anesthesia after a 20-min baseline (0 min) period

Time (min)
0 1–20 21–40 41–60 61–80 81–100 101–120 121–140 141–160 161–180 181–200 201–220 221–240 241–260 261–280 281–300
P1 latency
 O2 1253 ± 91 1249 ± 86 1245 ± 89 1244 ± 90 1240 ± 90 1245 ± 85 1243 ± 78 1242 ± 78 1248 ± 78 1247 ± 79 1247 ± 81 1245 ± 81 1249 ± 87 1262 ± 95a 1261 ± 92a 1258 ± 89a
 No O2 1274 ± 34 1287 ± 38 1283 ± 41 1277 ± 37 1275 ± 38 1275 ± 38 1279 ± 48 1275 ± 41 1288 ± 35 1300 ± 42 1299 ± 25 1293 ± 22 1297 ± 26 1280 ± 30b 1278 ± 36b 1275 ± 35b
N1 latency
 O2 1551± 101 1540 ± 97 1532 ± 95 1524 ± 100 1523 ± 99 1525 ± 93 1524 ± 93 1526 ± 82 1529 ± 83 1527 ± 80 1523 ± 84 1531 ± 81 1529 ± 84 1533 ± 90a 1538 ± 94a 1537 ± 98a
 No O2 1553 ± 47 1552 ± 45 1545 ± 40 1544 ± 37 1542 ± 40 1549 ± 49 1555 ± 64 1549 ± 35 1564 ± 39 1570 ± 36 1562 ± 25 1568 ± 32 1563 ± 27 1569 ± 33b 1570 ± 39b 1563 ± 33b
P2 latency
 O2 1932 ± 92 1915 ± 87 1918 ± 86 1906 ± 85 1903 ± 92 1898 ± 92 1893 ± 97 1900 ± 84 1901 ± 80 1903 ± 82 1896 ± 84 1886 ± 82 1889 ± 89 1907 ± 84a 1905 ± 96a 1904 ± 94a
 No O2 1935 ± 41 1930 ± 36 1925 ± 26 1925 ± 43 1921 ± 41 1925 ± 49 1920 ± 41 1918 ± 36 1919 ± 29 1921 ± 29 1913 ± 29 1915 ± 24 1911 ± 28 1913 ± 35b 1906 ± 35b 1893 ± 9b
P1–N1 amplitude
 O2 1.10 ±0.27 1.11 ±0.26 1.14 ± 0.28 1.14 ± 0.27 1.15 ±0.24 1.17 ± 0.30 1.13 ± 0.28 1.15 ± 0.28 1.18 ± 0.26 1.14 ± 0.32 1.19 ± 0.29 1.17 ± 0.30 1.14 ± 0.30 1.00 ± 0.07a 1.06 ± 0.10a 1.07 ± 0.10a
 No O2 0.97 ±0.30 0.97 ±0.25 0.96 ± 0.30 0.94 ± 0.34 0.95 ±0.34 0.95 ± 0.38 0.95 ± 0.36 0.95 ± 0.34 0.96 ± 0.30 0.89 ± 0.31 0.88 ± 0.32 0.91 ± 0.32 0.95 ± 0.38 0.79 ± 0.18b 0.85 ± 0.26b 0.84 ± 0.25b
P2–N1 amplitude
 O2 0.94 ±0.40 0.97 ±0.42 1.06 ± 0.35 1.00 ± 0.36 1.01 ±0.33 0.99 ± 0.31 1.02 ± 0.38 1.02 ± 0.38 0.97 ± 0.37 0.94 ± 0.33 0.90 ± 0.30 0.85 ± 0.32 0.85 ± 0.26 0.82 ± 0.20a 0.83 ± 0.18a 0.84 ± 0.18a
 No O2 0.91 ±0.42 0.93 ±0.43 0.91 ± 0.40 0.92 ± 0.36 0.89 ±0.39 0.85 ± 0.47 0.83 ± 0.46 0.85 ± 0.41 0.82 ± 0.37 0.75 ± 0.35 0.72 ± 0.31 0.71 ± 0.31 0.71 ± 0.30 0.61 ± 0.24b 0.60 ± 0.29b 0.65 ± 0.34b
Threshold
 O2 −10.5 ± 0.0 −11.0 ± 1.2 −10.5 ± 0.0 −10.5 ± 0.0 −10.5 ± 1.9 −10.0 ± 1.2 −10.0 ± 1.2 −10.5 ± 1.9 −9.5 ± 1.6 −10.5 ± 0.0 −10.0 ± 1.2 −11.5 ± 1.6 −10.0 ± 1.2 −9.9 ± 1.3a −10.5 ± 0.0a −10.5 ± 0.0a
 No O2 −9.5 ± 1.6 −11.0 ± 2.3 −10.5 ± 0.0 −9.5 ± 1.6 −11.0 ± 2.3 −10.5 ± 2.7 −8.5 ± 1.6 −8.5 ± 1.6 −10.0 ± 1.2 −9.5 ± 1.6 −10.0 ± 2.3 −10.0 ± 1.2 −10.0 ± 1.2 −12.0 ± 1.7b −12.0 ± 1.7b −11.3 ± 1.5b

VsEP latencies (µs) and amplitudes (µV) obtained at +6dB and 1.0 g/ms and response thresholds over time are shown. Results from O2-supplemented and nonsupplemented groups under urethane–xylazine anesthesia are represented. Each time period was characterized by averaging 4 or 5 consecutive measurements at approximately 5-min intervals. Brain temperature was controlled at 36.0 ± 0.2 °C, and rectal temperatures were maintained at 37.0 ± 0.2 °C in all animals. Data are shown as mean ± 1 SD of 6 animals, except where noted. Sample size decreased after 240 minutes because some animals were euthanized.

a

n = 5.

b

n = 4.